AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
Aurora Cannabis urged shareholders to take no action regarding Curaleaf Holdings' hostile takeover bid, asserting the offer attempts to undervalue its world-class EU-GMP infrastructure and global medical footprint. The company defended its operational strength, citing 17% year-over-year growth in international net revenue and three consecutive years of positive adjusted EBITDA as evidence its transformation is working.
Key figures
- Revenue Yoy
- 17%
- Offer duration days
- 105
- Adjusted ebitda status
- 3 consecutive years of positive adjusted EBITDA
- German reimbursement share
- < 10%
- International net revenue growth
- 17%
- Production capacity increase 5yr
- > 40%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.